News and Trends 14 Feb 2023Minoryx Therapeutics announces X-linked adrenoleukodystrophy data Minoryx Therapeutics has announced that data from its phase 2/3 ADVANCE clinical trial of lead candidate, leriglitazone, has been published… February 14, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 14 Nov 2022Minoryx and Neuraxpharm form alliance to get rights to new therapy for rare CNS disease Minoryx Therapeutics and Neuraxpharm Group have announced a strategic alliance for the European rights to a new therapy for rare… November 14, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2022Minoryx and Neuraxpharm announce license agreement to further X-ALD treatment Minoryx Therapeutics and Neuraxpharm Group have announced the completion of a strategic license agreement. Minoryx is a biotech company that… November 10, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 8 Oct 2018Behind the Scenes of the Spanish Biotech Industry’s Boom The Spanish biotech industry is booming, but from my conversations with industry players elsewhere in Europe, it seems the country’s… October 8, 2018 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 26 Sep 2018Spanish Biotech Raises €21.3M To Advance Rare Disease Pipeline Rare genetic diseases in the central nervous system may be less of a headache in future, as Barcelona-based biotech Minoryx… September 26, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 20 Feb 2018A New Biotech Hopes to Bring Us the Next Generation of Rare Metabolic Disorder Drugs Barcelona-based biotech, Minoryx, has spun out Gain Therapeutics to develop the next generation of drugs for rare metabolic disorders like GM1… February 20, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 8 Jan 2018And We’re Off! First Patient Dosed in this Spanish Biotech’s Rare Disease Trial Minoryx Therapeutics has dosed the first patient in its Phase II/III trial for patients with adrenomyeloneuropathy, a condition that affects 1… January 8, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
Interview 10 Jul 2017Meet the CEO of Minoryx, the Spanish Biotech Fighting Rare Disease I spoke with Marc Martinell, CEO of Minoryx, to learn first-hand how his company in Barcelona is bringing new hope… July 10, 2017 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2017A Potential First Treatment for a Rare Genetic Disease clears Phase I Minoryx Therapeutics has successfully completed a Phase I trial for its lead compound MIN-102 targeting X-linked adrenoleukodystrophy (X-ALD). The Spanish biotech Minoryx… March 21, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
News and Trends 28 Feb 2017It’s Global Rare Disease Day! What Cures is Biotech Cooking Up? We've compiled a list of some of the latest advances of biotech in the field of rare disease to contribute… February 28, 2017 - 5 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 Feb 2017Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017 As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from Barcelona, one of the hottest… February 22, 2017 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 15 Oct 2015Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease Minoryx Therapeutics is a Barcelona based Rare-disease specialist who has a panel of orphan-drug experts for their discovery program. Now… October 15, 2015 - 2 minutesmins - By Dani Bancroft Share WhatsApp Twitter Linkedin Email